CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,198,713 | +475.8% | 192,926 | +546.0% | 0.02% | +466.7% |
| Q4 2022 | $555,508 | -58.0% | 29,866 | -71.0% | 0.00% | -66.7% |
| Q3 2022 | $1,322,000 | +551.2% | 103,008 | +321.6% | 0.01% | +800.0% |
| Q1 2022 | $203,000 | -17.5% | 24,431 | -32.6% | 0.00% | 0.0% |
| Q4 2021 | $246,000 | +30.2% | 36,271 | -26.1% | 0.00% | -50.0% |
| Q1 2020 | $189,000 | +243.6% | 49,050 | +242.2% | 0.00% | – |
| Q2 2019 | $55,000 | -21.4% | 14,332 | -60.9% | 0.00% | – |
| Q4 2018 | $70,000 | -40.2% | 36,700 | +18.3% | 0.00% | -100.0% |
| Q3 2018 | $117,000 | +50.0% | 31,012 | +24.0% | 0.00% | – |
| Q2 2018 | $78,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |